As of 1:24pm ET
| +0.05 / +2.25%|
The 5 analysts offering 12-month price forecasts for HTG Molecular Diagnostics Inc have a median target of 6.00, with a high estimate of 8.00 and a low estimate of 5.00. The median estimate represents a +164.32% increase from the last price of 2.27.
The current consensus among 5 polled investment analysts is to Buy stock in HTG Molecular Diagnostics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.